The Casein Peptone Market is expected to expand at a 4.2% CAGR from 2023 to 2033, from US$ 395.6 million in 2023 to US$ 595.7 million in 2033.
Peptone's Advantageous Qualities to Increase Product Demand in a Variety of Application Sectors
Peptone is a popular microbiological growth media. Peptone is a great natural source of peptides, proteins, and amino acids in growth media because it is a water-soluble mixture of polypeptides and amino acids that are widely used in many biological and biotechnological applications. It also acts as a nitrogen source in many complex medias. It does not coagulate when heated, is soluble in water, and is thus particularly well suited for inclusion in microbiological culture media.
Peptone has proven to be an effective supplement and an alternative to serums in the proliferation of mammalian cells and the production of biological products. Furthermore, peptone supplementation has various advantages in cell culture applications since it contains low molecular weight nutrients, peptides, and free amino acids that are appropriate for this application.
The manufacturers are aggressively investing in the development of BSE- bovine spongiform encephalopathy and GMO-free peptones and extracts, which are two of the most important safety concerns. Plants are being employed as a natural source of peptone synthesis, not only to eliminate the potential of BSE; but also to allow specific microbes to develop quickly. This is expected to have a positive impact on market development over the forecast period.
| Report Attribute | Details |
|---|---|
| Casein Peptone Market Value (2023) | US$ 395.6 million |
| Casein Peptone Market Anticipated Value (2033) | US$ 595.7 million |
| Casein Peptone Market Growth Rate (2023 to 2033) | 4.2% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Casein Peptone Market was accounted for US$ 380.4 million in 2022, securing a 2.8% CAGR from 2017 to 2022. Global Market Absolute Dollar Growth is US$ 200.1 million.
The casein peptone market has been registering high demand from the expanding pharmaceutical industry. Casein peptone plays a crucial role in production of culture media for laboratory tests. As the diagnostic and pharmaceutical industry is expanding steadily, the demand for acid casein peptone, calcium casein peptone, and others is skyrocketing. Furthermore, the rise in vaccine production process is creating growth opportunities for the market.
According to the World Health Organization (WHO), 172 countries and multiple candidate vaccines are engaged in discussions to potentially participate in COVAX while countries such as China, Russia, India, Japan, and others are starting with their vaccine production processes.
Casein peptone being an integral part of producing vaccines, is gaining considerable traction. As casein peptone is required in the manufacturing of enzymes, toxins, and other biological products, the growth in biochemical industry is catering to the rising demand for casein peptone.
| Historical CAGR (2017 to 2022) | 2.8% |
|---|---|
| Forecast CAGR (2023 to 2033) | 4.2% |
As per the FMI analysts, a valuation of US$ 595.7 million by 2033 end is estimated for the market.
| Year | Valuation |
|---|---|
| 2016 | US$ 296.61 million |
| 2021 | US$ 364.35 million |
| 2022 | US$ 380.4 million |
| 2023 | US$ 395.6 million |
| 2033 | US$ 595.7 million |
As casein peptone is costly, it is yet to be widely adopted by small to medium-scale pharmaceutical and biochemical companies and other institutes. Furthermore, casein peptone has disadvantages such as the presence of casein peptone interferes with the isolation of various products including specific carbohydrates, enzymes, toxins, and others.
The variation between the peptones even of the same brand often comes in the ways of ensuring production efficiency. These factors could hamper the growth of the market to an extent.
The COVID-19 pandemic has had a negative impact on the market as well, causing the decline in demand in the earlier part of 2020, which is going to last till year 2021.
Principal Consultant
| Country | The United States |
|---|---|
| CAGR (2017 to 2022) | 4.0% |
| Valuation (2023 to 2033) | US$ 80.4 million |
| Country | The United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.3% |
| Valuation (2023 to 2033) | US$ 12.7 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 2.8% |
| Valuation (2023 to 2033) | US$ 63.1 million |
| Country | Europe |
|---|---|
| CAGR (2017 to 2022) | 3.8% |
| Valuation (2023 to 2033) | US$ 38.3 million |
| Country | India |
|---|---|
| CAGR (2017 to 2022) | 2.8% |
| Valuation (2023 to 2033) | US$ 31.2 million |
East Asia is presently leading in the global market and is anticipated to remain dominant through the forecast period. The increasing requirement for biomass production, coupled with increasing research & development activities in countries such as China, Japan, South Korea, and others is projected to drive East Asia market in the coming years.
East Asia market is expected to gain significant impetus from the increasing demand from its well-developed cosmetics industry. According to FMI, China to emerge as the dominant economy in the coming years. Japan remains lucrative throughout the forecast period.
Europe is the second leading in the casein peptone market and is set to grow steadily in the coming years. The presence of a well-established pharmaceutical industry is bolstering growth in Europe. With the rising demand for casein peptone in diagnostic media production, Europe market is set to exhibit exponential growth in the coming years.
Several vaccine production initiatives and trials are catering to the growth in Europe. For instance, Britain has launched the West’s first mass coronavirus vaccination in December; 2020.
EU-4 (Germany, France, Italy, Spain) are expected to lead in Europe in the coming years.
The surging research & development activities conducted across the biotech & pharmaceutical industry are driving North America market.
North America also is the notable importer of casein peptone across the globe. The highly advanced infrastructure for biochemical research, enzyme production, diagnostic media production, and others is forecasted to grow North America market.
The United States is expected to remain dominant in North America peptone powder market soon.
Presently, diagnostic media production is leading in the global market in terms of application. Diagnostic media is a special mixture of specific nutrient substances on which microorganisms are grown in order to determine the species to which they belong. Diagnostic media production includes the production of basic simple reagents for health laboratory services.
Casein peptone being highly efficient in increasing the micro-organisms in the production process is widely required in the production of various diagnostic media such as selective media, transport media, storage media, basal media, enriched media, indicator media, and others.
The growing usage of microbiological cultures is anticipated to boost the growth of the market in forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The casein peptone market is set to exhibit steady growth during the forecast period. In order to capitalize on the market potential, the casein peptone manufacturers are focusing on launching a wide range of casein peptone products including calcium casein peptone, acid casein peptone, and others.
| Attribute | Details |
|---|---|
| Market Size Value In 2023 | US$ 395.6 million |
| Market Size Value in End of Forecast (2033) | US$ 595.7 million |
| Market Analysis | US$ million for Value |
| Key Region Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific Excluding Japan; The Middle East and Africa; Japan |
| Key Segments | By Application, By Region |
| Key Companies Profiled | Apollo Scientific Ltd; Amyl Media Pty Ltd; Neogen Corporation; Merck KGaA; MP Biomedicals LLC; Carl Roth GmbH & Co. KG; Azelis Americas, LLC; Thermo Fisher Scientific, Inc.; Biolife Italiana S.r.l. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 395.6 million in 2023.
Apollo Scientific Ltd, Amyl Media Pty Ltd, and Neogen Corporation are key casein peptone market players.
Recombinant casein peptone is likely to remain preferred through 2033.
Players opt for partnerships and collaborations.
India, Japan, and China dominate the Asian market.
1. Executive Summary | Casein Peptone Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Application, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Application, 2023 to 2033 5.3.1. Diagnostic Media Production 5.3.2. Industrial Fermentation 5.3.3. Biomass Production 5.3.4. Enzyme Production 5.3.5. Vaccine Production 5.3.6. Other Applications 5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Academic & Research Institutes 6.3.2. Biopharmaceutical Companies 6.3.3. Contract Research Laboratories 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Application 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Application 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Application 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Application 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Singapore 11.2.1.5. Thailand 11.2.1.6. Indonesia 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia Pacific 11.2.2. By Application 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By End User 11.4. Key Takeaways 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Application 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. USA 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2022 13.1.2.1. By Application 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2022 13.2.2.1. By Application 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2022 13.3.2.1. By Application 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2022 13.4.2.1. By Application 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2022 13.5.2.1. By Application 13.5.2.2. By End User 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2022 13.6.2.1. By Application 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2022 13.7.2.1. By Application 13.7.2.2. By End User 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2022 13.8.2.1. By Application 13.8.2.2. By End User 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2022 13.9.2.1. By Application 13.9.2.2. By End User 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2022 13.10.2.1. By Application 13.10.2.2. By End User 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2022 13.11.2.1. By Application 13.11.2.2. By End User 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2022 13.12.2.1. By Application 13.12.2.2. By End User 13.13. Singapore 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2022 13.13.2.1. By Application 13.13.2.2. By End User 13.14. Thailand 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2022 13.14.2.1. By Application 13.14.2.2. By End User 13.15. Indonesia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2022 13.15.2.1. By Application 13.15.2.2. By End User 13.16. Australia 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2022 13.16.2.1. By Application 13.16.2.2. By End User 13.17. New Zealand 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2022 13.17.2.1. By Application 13.17.2.2. By End User 13.18. GCC Countries 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2022 13.18.2.1. By Application 13.18.2.2. By End User 13.19. South Africa 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2022 13.19.2.1. By Application 13.19.2.2. By End User 13.20. Israel 13.20.1. Pricing Analysis 13.20.2. Market Share Analysis, 2022 13.20.2.1. By Application 13.20.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Application 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Apollo Scientific Ltd 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.1.5.2. Product Strategy 15.1.1.5.3. Channel Strategy 15.1.2. Amyl Media Pty Ltd 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.2.5.2. Product Strategy 15.1.2.5.3. Channel Strategy 15.1.3. Neogen Corporation 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.3.5.2. Product Strategy 15.1.3.5.3. Channel Strategy 15.1.4. Merck KGaA 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.4.5.2. Product Strategy 15.1.4.5.3. Channel Strategy 15.1.5. MP Biomedicals LLC 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.5.5.2. Product Strategy 15.1.5.5.3. Channel Strategy 15.1.6. Carl Roth GmbH & Co. KG 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.6.5.2. Product Strategy 15.1.6.5.3. Channel Strategy 15.1.7. Azelis Americas, LLC 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.7.5.2. Product Strategy 15.1.7.5.3. Channel Strategy 15.1.8. Thermo Fisher Scientific, Inc. 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.8.5.2. Product Strategy 15.1.8.5.3. Channel Strategy 15.1.9. Biolife Italiana S.r.l. 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.9.5.2. Product Strategy 15.1.9.5.3. Channel Strategy 15.1.10. Nu-Tek BioScience LLC 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.10.5.2. Product Strategy 15.1.10.5.3. Channel Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Food and Beverage Insights
View Reports
Casein Peptone Market
